MARKET

HSKA

HSKA

Heska
NASDAQ

Real-time Quotes | Nasdaq Last Sale

92.05
-0.78
-0.84%
After Hours: 92.05 0 0.00% 16:00 07/02 EDT
OPEN
93.99
PREV CLOSE
92.83
HIGH
95.14
LOW
91.78
VOLUME
38.29K
TURNOVER
--
52 WEEK HIGH
110.90
52 WEEK LOW
50.00
MARKET CAP
864.53M
P/E (TTM)
-91.5283
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HSKA stock price target is 79.67 with a high estimate of 90.00 and a low estimate of 62.00.

EPS

HSKA News

More
Hedge Funds Have Never Been This Bullish On Heska Corp (HSKA)
Insider Monkey · 5d ago
Edited Transcript of HSKA earnings conference call or presentation 7-May-20 3:00pm GMT
Thomson Reuters StreetEvents · 06/15 14:26
Heska's (HSKA) CEO Kevin Wilson on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/09 05:01
Heska Corporation (HSKA) Q1 2020 Earnings Call Transcript
MotleyFool.com · 05/08 04:31
Heska (HSKA) Reports Q1 Loss, Misses Revenue Estimates
Zacks · 05/07 14:25
Heska: Q1 Earnings Insights
Benzinga · 05/07 13:32
Heska Corporation Reports First Quarter 2020 Results
PR Newswire · 05/07 13:00
Heska: Q1 Earnings Insights
Shares of Heska (NASDAQ:HSKA) remained unaffected at $70.17 after the company reported Q1 results. Quarterly Results Earnings per share were down 366.67% over the past year to ($0.14), which beat the estimate of ($0.25).
Benzinga · 05/07 12:32

Industry

Medical Equipment, Supplies & Distribution
+0.80%
Healthcare Equipment & Supplies
+0.92%

Hot Stocks

Symbol
Price
%Change

About HSKA

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.
More

Webull offers kinds of Heska Corp stock information, including NASDAQ:HSKA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSKA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HSKA stock methods without spending real money on the virtual paper trading platform.